Addition of inhaled corticosteroids to systemic immunosuppression after lung transplantation: A double-blind, placebo-controlled trial

Transplantation

Volumn 73, Issue 11, 2002, Pages 1793-1799

  Whitford, Helen ^a   Walters, E Haydn ^a   Levvey, Bronwyn ^a   Kotsimbos, Tom ^a   Orsida, Bernadette ^a   Ward, Chris ^a   Pais, Michael ^a   Reid, Sue ^a   Williams, Trevor ^a   Snell, Greg ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FLUTICASONE PROPIONATE;

ADULT; ARTICLE; ASTHMA; BRONCHIOLITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE INJURY; INFLAMMATION; LUNG LAVAGE; LUNG TRANSPLANTATION; LYMPHOCYTE COUNT; MALE; MORBIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; STEROID THERAPY;

EID: 0037096617     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200206150-00016     Document Type: Article

References (35)

1. Lung transplantation
2. New trends in lung preservation: A collective review
3. The Registry of the International Society for Heart and Lung Transplantation: Sixteenth official report - 1999
4. Bronchiolitis obliterans after lung transplantation: A review
5. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts
6. Immunopathological changes in the airways of stable lung transplant recipients
7. Obliterative bronchiolitis after lung transplantation
8. Cytolytic therapy for the bronchiolitis obliterans syndrome complicating lung transplantation
9. Management of lung transplant rejection
10. Pharmacokinetics and pharmacodynamics of 15-deoxyspergualin in a canine renal allograft model of local immunosuppression
11. Intraportal delivery of immunosuppression to intrahepatic islet allograft recipients
12. Immunologic aspects of local immunosuppression in canine liver transplantation
13. Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992
14. Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease
15. Inhaled corticosteroids are beneficial in chronic obstructive pulmonary disease
16. Mechanisms in COPD: Differences from asthma
17. Endobronchial biopsy and bronchoalveolar lavage in stable lung transplant recipients and chronic rejection
18. Structural and inflammatory changes in COPD: A comparison with asthma
19. Effects of inhaled nebulized steroids (budesonide) on acute and chronic lung function in heart-lung transplant patients
20. A case report of a double-blind, randomized trial of inhaled steroids in a patient with lung transplant bronchiolitis obliterans
21. Transient effect of inhaled fluticasone on airway mucosal blood flow in subjects with and without asthma
22. Airway vascular changes in lung allograft recipients
23. Efficacy of inhaled cyclosporine in lung transplant recipients with refractory rejection: Correlation of intragraft cytokine gene expression with pulmonary function and histologic characteristics
24. Aerosolized cyclosporine in lung recipients with refractory chronic rejection
25. Development of fluticasone propionate and comparison with other inhaled corticosteroids
26. Relative safety and efficacy of inhaled corticosteroids
27. Is high-dose fluticasone propionate via a metered-dose inhaler and Volumatic as efficacious as nebulized budesonide in adult asthmatics?
28. Features of acute rejection that increase risk for chronic rejection
29. No objective benefit from steroids inhaled via a spacer in infants recovering from bronchiolitis
30. Randomized, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
31. Are inhaled glucocorticosteroids effective in chronic obstructive pulmonary disease?
32. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD
33. Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease
34. Multidrug resistance in lung allograft recipients: Possible correlation with the development of acute and chronic rejection
35. Aspergillus infection in single and double lung transplant recipients